drugset / Trial / NCT00751608

Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients

NCT00751608 ↗

Phase 2 Withdrawn Novartis Pharmaceuticals
RandomizedParallel-groupDouble-blindBasic science

Summary

This study will evaluate the effect of APL180 on endothelial function measured by forearm venous occlusion plethysmography in patients with familial hypercholesterolemia.

Timeline

Start
2006-09
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator APL180 Unknown — —